BioCentury
ARTICLE | Company News

amp biosimilars deal

June 29, 2015 7:00 AM UTC

amp granted an undisclosed Chinese pharma exclusive rights to commercialize ABY-021 in China. The humanized mAb is a biosimilar of an undisclosed compound in preclinical development for immunological...